Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-003195
Filing Date
2022-01-13
Accepted
2022-01-13 16:36:02
Documents
1
Period of Report
2022-01-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 11560
  Complete submission text file 0001209191-22-003195.txt   13557
Mailing Address 17 RUE DE SERENE PARIS I0 75008
Business Address 17 RUE DE SERENE PARIS I0 75008 33 1 53 05 41 13
Sofinnova Partners SAS (Reporting) CIK: 0001574139 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-41201 | Film No.: 22529419

Mailing Address 7-11 BOULEVARD HAUSSMANN PARIS I0 75009
Business Address 7-11 BOULEVARD HAUSSMANN PARIS I0 75009 33(0)1 76 23 41 00
Sofinnova Capital IX (Reporting) CIK: 0001849915 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-41201 | Film No.: 22529418

Mailing Address 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116 8445311834
CinCor Pharma, Inc. (Issuer) CIK: 0001868734 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations